Antibody-drug conjugates, or ADCs, have emerged as a significant class of cancer therapies over the past two decades. New...
The AACR Special Conference: Liquid Biopsy features experts exploring all facets of this exciting technological arena.
When Corrie Painter was diagnosed with angiosarcoma, an aggressive cancer in cells that line blood and lymph vessels, in...
Researchers are looking into urine tests that could detect cancers earlier, including lung, ovarian, pancreatic, colorectal, and more.
Melissa Davis, PhD, is putting health disparities under a lens. One that can take an aerial view of the...
Ten-year-old Michael Methner told his story about his experience being diagnosed with optic nerve glioma at the Rally for...
This quarter’s 16 approvals include a first-in-class cell therapeutic, a flurry of new options for EGFR-mutated lung cancer, and...
Several recent studies, including on presented at the AACR Conference on the Science of Cancer Health Disparities, have examined...
By Ross Uhrich, DMD, MBA, ARPA-H Program Manager for POSEIDON and NITRO programs, Health Science Futures Mission Office What...
This month, AACR's journals editors highlighted factors that may reduce pancreatic cancer risk, a new humanized mouse model, and...
Understanding pancreatic cancer’s strengths may provide clues to its weaknesses.